Get a Tirzepatide
Prescription Online
Tirzepatide is the active ingredient in Zepbound and Mounjaro, a dual GIP and GLP-1 agonist medication that targets appetite from two directions. Heally board-certified physicians can prescribe tirzepatide (Zepbound) when appropriate after a 15-minute telehealth consultation. No clinic visit. Your tirzepatide medication is delivered to your door within 24–48 hours.
Tirzepatide Online Program starting at $299 /month
Get Tirzepatide Prescription Online in 3 Clicks
100% online. Meet a doctor in 15 minutes. If prescribed, delivery in 24–48 hours.
Start your free consultationStep 1
Step 2
Step 3
Why Choose Heally to Get Tirzepatide
Results for Weight Loss with Tirzepatide
SURMOUNT-5 compared the two medications head-to-head: 751 adults took either tirzepatide or semaglutide for 72 weeks. Tirzepatide weight loss reached 20.2% on average, versus 13.7% for semaglutide.
Tirzepatide 15 mg
Average weight loss: 20.9%
Tirzepatide vs semaglutide
Head-to-head: 20.2% vs 13.7%
Individual results vary. Weight loss depends on dose, adherence, diet, and activity. Your doctor will set realistic goals at the free consultation.
Thinking about Switching to Tirzepatide?
Currently on semaglutide, liraglutide, or another GLP-1 and wondering whether a different medication fits you better? Or moving from compounded tirzepatide to an FDA-approved formulation? Your Heally doctor can guide your tirzepatide transition at your free consultation. Your provider plans the switch, including timing and your dose, and monitors how you respond.
Switch to TirzepatideAlready on Tirzepatide? Transfer Your Care to Heally
Already taking tirzepatide but stuck with slow refills, limited supply, or weak telehealth support from your current provider? Moving your tirzepatide treatment to Heally is simple. At your free consultation, your Heally doctor reviews your current dose and any recent labs and picks up exactly where your last provider left off — no treatment gap, no starting over.
Switch to HeallyAlready Taking Tirzepatide and Have Questions or Concerns?
Experiencing something unexpected during treatment, adjusting to a new dose, or wondering whether tirzepatide is still the right fit for your goals? These are exactly the questions Heally doctors are here for. A quick online consultation is all it takes to get clarity and a plan.
What our doctors can help with
- Adjusting your dose if your weight loss has plateaued
- Managing any discomfort in the early weeks of treatment
- Reviewing your progress and updating your treatment plan
- Answering questions about interactions with other medications
- Deciding whether to continue, switch, or pause treatment
How Much Does Tirzepatide Cost at Heally?
- No membership and no subscription, ever
- Self-pay pricing with no insurance required
- Zepbound, prescribed when your doctor decides it is appropriate
- Tirzepatide prescription based on a telehealth consultation
- Ongoing dose adjustments and refills online
What Heally Patients Say about Tirzepatide
Patients have shared their experiences with Heally weight loss programs and tirzepatide treatment, with many highlighting noticeable changes in their health and habits. Weight loss results vary and depend on diet, physical activity, and consistent use of the medication.
The Heally care team is top notch. They really took the time to answer all my questions and concerns.
Amanda is a true gem. I feel bad cause our consutlation took almost an hour. I was scared to start Tirzepatide, but she really took care of me and my concerns.
Ready to start your own weight loss journey?
Book your free consultationIndividual results vary and are not guaranteed. Weight loss depends on dose, adherence, diet, and physical activity. Reviews reflect individual experiences and are not a substitute for medical advice.
Meet the Doctors behind Your Tirzepatide Care
Your prescription is reviewed and written by board-certified physicians and licensed clinicians, each trained at respected U.S. medical institutions and licensed to practice in your state.
Dr. Jason Hechtman, M.D.
Internal Medicine
Internal Medicine physician with 30+ years focused on metabolic health, GLP-1 weight loss, and obesity management.
- M.D., Wayne State University
- 30+ years of clinical experience
Dr. Johnathan Miller, M.D.
Weight Management
Board-certified physician supporting medical weight loss alongside the behavioral and appetite factors that drive it.
- M.D., Columbia University
- Board-certified psychiatrist
Dr. James Reichman, M.D.
Men's Weight Loss
Board-certified physician with 30+ years in men's health, hormone balance, and medical weight loss.
- M.D., George Washington University
- 30+ years of clinical experience
Dr. Benjamin Krasne, M.D.
Metabolic Health
Board-certified Internal Medicine physician specializing in metabolic health and medical weight loss.
- M.D., University of Miami
- Metabolic & weight loss medicine
Get Tirzepatide Delivered in 24–48 Hours to Your Home
Ready to get started? Book a free consultation today. If your provider decides treatment is appropriate, you can get your prescription the same day and receive your medication at home within 24–48 hours.
Get startedHow to Get Tirzepatide for Weight Loss
Zepbound (tirzepatide) is FDA-approved for chronic weight management and acts on both GIP and GLP-1 receptors. In SURMOUNT-1, Zepbound produced 20.9% average weight loss at 15 mg over 72 weeks. Book an online doctor consultation to see if Zepbound is right for you.
Mounjaro (tirzepatide) uses the same dual GIP and GLP-1 mechanism as Zepbound. FDA-approved for type 2 diabetes; not approved for weight loss. For chronic weight management, ask your doctor about Zepbound.
Tirzepatide vs Other Weight Loss Medications: What Is the Difference?
How does it compare to similar medications?
| Medication | Mechanism | Dosing | Avg. weight loss | Route |
|---|---|---|---|---|
| Tirzepatide (Zepbound) |
Dual GIP and GLP-1 agonist | Once weekly | 20.9% at 15 mg (SURMOUNT-1) | Injection |
| Semaglutide (Wegovy) |
GLP-1 agonist | Once weekly (injection) or once daily (pill) | 14.9% (STEP 1) | Injection or oral |
| Liraglutide (Saxenda) |
GLP-1 agonist | Once daily | 8.0% (SCALE) | Injection |
Each figure is the average weight loss from that medication's own pivotal trial, so the trials differ in design and population. The one direct comparison is SURMOUNT-5, where tirzepatide and semaglutide were tested head-to-head in the same 751 adults: 20.2% versus 13.7%.
Tirzepatide vs semaglutide
Tirzepatide adds GIP receptor activation on top of GLP-1. In SURMOUNT-5, the head-to-head trial of 751 adults, tirzepatide produced 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks. Both are once-weekly injections. Semaglutide has a longer real-world record and is also available as a once-daily pill, while tirzepatide is injection-only.
Tirzepatide vs liraglutide
Tirzepatide (Zepbound) is dosed once weekly, while liraglutide (Saxenda) is dosed once daily. Saxenda was approved for weight management in 2014; in the SCALE trial, it produced 8.0% average weight loss vs 2.6% with placebo at 56 weeks. These figures come from separate trials, not a head-to-head comparison.
Tirzepatide injection vs the Wegovy pill
Tirzepatide is a weekly injection that requires cold storage. The Wegovy pill (oral semaglutide 25 mg) avoids needles but requires daily dosing and a morning fasting protocol.
Frequently Asked Questions about Tirzepatide
Tirzepatide Health and News
Tirzepatide Dosing Guide
Following the prescribed tirzepatide dosing schedule matters for safety and tolerability. Here is how dose escalation typically works…
Tirzepatide vs Semaglutide: What is the Difference?
A head-to-head look at how the two leading GLP-1 medications compare on mechanism, dosing, and average weight loss.
Important Disclaimers
Disclaimer: Individual results may vary. Zepbound® (tirzepatide) is FDA-approved for chronic weight management. Mounjaro® (tirzepatide) is FDA-approved for type 2 diabetes and is not approved for weight loss. Weight-loss outcomes are influenced by many factors, including diet, physical activity, gender, baseline weight, and adherence to treatment plans.
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Ozempic®, Rybelsus®, and Wegovy® are registered trademarks of Novo Nordisk A/S. Trulicity® is also a registered trademark of Eli Lilly. Saxenda® and Victoza® are registered trademarks of Novo Nordisk. This website is not affiliated with, endorsed by, or sponsored by these companies. Mentions are for educational and comparative purposes only.
Common side effects of tirzepatide (Zepbound®, Mounjaro®) may include nausea, diarrhea, vomiting, constipation, decreased appetite, fatigue, headache, and indigestion. Serious risks include pancreatitis, gallbladder problems, depression, kidney issues, and a potential risk of thyroid C-cell tumors. Do not use tirzepatide if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tirzepatide should not be used during pregnancy or while breastfeeding. Safety data in these populations is limited. Do not use if you’ve had an allergic reaction to tirzepatide. Monitor for mental health changes, including depression or suicidal thoughts, and contact a provider if symptoms occur.
Your provider sets your dose and schedule. Mounjaro® is FDA-approved for type 2 diabetes; Zepbound® is FDA-approved for chronic weight management in adults who meet eligibility criteria.
Access to medications, coupons, or programs may vary based on insurance, location, and pharmacy participation. Heally is not responsible for third-party pricing, availability, or reimbursement policies.
This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider for medical diagnosis and personalized treatment plans.
For more information, please refer to these official FDA and manufacturer sources: